Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Goreisan in transurethral resection of prostate
jRCT1091220213Completed
- Sponsor
- Osaka Medical and Pharmaceutical University
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of oreongsan in benign prostatic hyperplasia (BPH) and Transurethral Resection Syndrome (TURS) (2 arms), sponsored by Osaka Medical and Pharmaceutical University. Primary endpoints: Change in serum sodium and Occurrence of TUR syndrome. Started Apr 2015; status: completed.
02
Drugs
oreongsan
03
Conditions
benign prostatic hyperplasia (BPH)Transurethral Resection Syndrome (TURS)
Beyond the preview
Go deeper on jRCT1091220213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220213.